From: Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
Clinical gold standard diagnosis | Summed [n] | 6-[18F]FDOPA abnormal [n, %] | N1 abnormal [n, %] |
---|---|---|---|
IPS | 18 | 18 (100%) | 17 (94%) |
APS | 9 | 7 (77%) | 5 (55%) |
Progressive supranuclear palsy | 6 | 5 (83%) | 3 (50%) |
Corticobasal degeneration | 2 | 1 (50%) | 1 (50%) |
Multiple system atrophy | 1 | 1 (100%) | 1 (100%) |
Non-parkinsonian movement disorders | 16 | 1 (6%) | 4 (25%) |
Essential tremor | 6 | 0 (0%) | 2 (33%) |
Vascular parkinsonism | 3 | 0 (0%) | 1 (33%) |
Drug-induced parkinsonism | 2 | 0 (0%) | 0 (0%) |
Restless legs syndrome | 1 | 1 (100%) | 0 (0%) |
Ataxia | 1 | 0 (0%) | 0 (0%) |
Motor neuron disease | 1 | 0 (0%) | 1 (100%) |
Alzheimer’s disease | 1 | 0 (0%) | 0 (0%) |
Huntington’s disease | 1 | 0 (0%) | 0 (0%) |